Alternate-day Dosing with Statins - 17/01/13
, Adam J. Baumgarten, MD b, William L. Fritz, MS c, d, Paul E. Nolan, PharmD c
Requests for reprints should be addressed to Frank I. Marcus, MD, University of Arizona Medical Center, Sarver Heart Center, 1501 N. Campbell Ave, Tucson, AZ 85724-5037Abstract |
The duration of the cholesterol-lowering effect of statins is considerably longer than the duration of the pharmacokinetic half-life of these drugs. The long duration of pharmacologic effects provides the rational for the efficacy of intermittent dosing that provides nearly the equivalent low-density lipoprotein cholesterol reduction compared with daily dosing. Review of studies comparing alternate-day dosing with daily dosing of statins indicates that the magnitude of low-density lipoprotein cholesterol reduction with alternate-day dosing is nearly the same, with obvious cost savings. It is possible that the adverse effects of statins, such as myalgia or diabetes, may be related to the cumulative amount of drug ingested over time, and if so, the adverse effects may be decreased by alternate-day dosing.
El texto completo de este artículo está disponible en PDF.Keywords : Dosing, Low-density lipoprotein cholesterol, Statins
Esquema
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
Vol 126 - N° 2
P. 99-104 - février 2013 Regresar al número
Artículo precedente
- Leading Avoidable Cause of Premature Deaths Worldwide: Case for Obesity
- Charles H. Hennekens, Felicita Andreotti
- Ineligibility for Anticoagulation in Patients with Atrial Fibrillation
- Ian del Conde, Jonathan L. Halperin
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?